Cargando…
CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007870/ https://www.ncbi.nlm.nih.gov/pubmed/36915573 http://dx.doi.org/10.21037/tcr-22-2880 |
| _version_ | 1784905625669468160 |
|---|---|
| author | Jain, Swati Ma, Kevin Morris, Luc G. T. |
| author_facet | Jain, Swati Ma, Kevin Morris, Luc G. T. |
| author_sort | Jain, Swati |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10007870 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100078702023-03-12 CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy Jain, Swati Ma, Kevin Morris, Luc G. T. Transl Cancer Res Editorial Commentary AME Publishing Company 2023-02-21 2023-02-28 /pmc/articles/PMC10007870/ /pubmed/36915573 http://dx.doi.org/10.21037/tcr-22-2880 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Jain, Swati Ma, Kevin Morris, Luc G. T. CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy |
| title | CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy |
| title_full | CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy |
| title_fullStr | CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy |
| title_full_unstemmed | CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy |
| title_short | CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy |
| title_sort | cd66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007870/ https://www.ncbi.nlm.nih.gov/pubmed/36915573 http://dx.doi.org/10.21037/tcr-22-2880 |
| work_keys_str_mv | AT jainswati cd66basaprognosticandpredictivebiomarkerinpatientswithnonsmallcelllungcancertreatedwithcheckpointblockadeimmunotherapy AT makevin cd66basaprognosticandpredictivebiomarkerinpatientswithnonsmallcelllungcancertreatedwithcheckpointblockadeimmunotherapy AT morrislucgt cd66basaprognosticandpredictivebiomarkerinpatientswithnonsmallcelllungcancertreatedwithcheckpointblockadeimmunotherapy |